NBY logo

NovaBay Pharmaceuticals (NBY) Selling, General & Administrative Expenses

Annual SGA

$12.83 M
-$2.46 M-16.07%

December 1, 2023

Summary

Performance

1-Year Change

-16.07%

3-Year Change

+5.99%

5-Year Change

-31.08%

15-Year Change

-42.59%

NBY SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.5%
NBY annual SGA is higher than 29.5% of companies in Healthcare sector

High & Low

All-time High

$22.35 M
NBY annual SGA is currently -42.59% below its historical high of $22.35 million

3-Year Low

$12.83 M
NBY annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYexpensesmetrics:

Annual Total Expenses

$19.73 M
NBY annual total expenses is $19.73 million

Annual Operating Expenses

$12.90 M
NBY annual total operating expenses is $12.90 million

Annual Cost Of Goods Sold

$6.83 M
NBY annual cost of goods sold is $6.83 million

Annual Interest Expense

-
NBY annual interest expense value is unknown

Quarterly SGA

$2.65 M
+$14.00 K+0.53%

September 1, 2024

Summary

Performance

3-Month Change

+0.53%

1-Year Change

+12.48%

3-Year Change

-4.26%

5-Year Change

-4.26%

NBY Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.37%
NBY quarterly SGA is higher than 22.37% of companies in Healthcare sector

High & Low

All-time High

$6.83 M
NBY quarterly SGA is currently -61.19% below its historical high of $6.83 million

3-Year Low

$2.36 M
NBY quarterly SGA is currently +12.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYexpensesmetrics:

Quarterly Total Expenses

$3.50 M
NBY quarterly total expenses is $3.50 million

Quarterly Operating Expenses

$2.65 M
NBY quarterly total operating expenses is $2.65 million

Quarterly Cost Of Goods Sold

$848.00 K
NBY quarterly cost of goods sold is $848.00 thousand

Quarterly Interest Expense

$138.00 K
NBY quarterly interest expense is $138.00 thousand

TTM SGA

-$715.57 M
-$16.57 M-2.37%

September 1, 2024

Summary

Performance

3-Month Change

-5558.58%

1-Year Change

-5853.52%

3-Year Change

-5659.08%

5-Year Change

-5659.08%

NBY TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.83%
NBY TTM SGA is higher than 53.83% of companies in Healthcare sector

High & Low

All-time High

-$7.79 M

3-Year Low

-$715.57 M
NBY TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYexpensesmetrics:

Annual Total Expenses

$19.73 M
NBY annual total expenses is $19.73 million

Annual Operating Expenses

$12.90 M
NBY annual total operating expenses is $12.90 million

TTM Cost Of Goods Sold

$5.97 M
NBY TTM cost of goods sold is $5.97 million

TTM Interest Expense

$871.00 K
NBY TTM interest expense is $871.00 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$12.83 M
NBY annual SGA is $12.83 million

Annual Operating Expenses

$12.90 M
NBY annual total operating expenses is $12.90 million

Annual Cost Of Goods Sold

$6.83 M
NBY annual cost of goods sold is $6.83 million

NBY Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.1%+12.5%-5853.5%
3 y3 years+6.0%-4.3%-5659.1%
5 y5 years-31.1%-4.3%-5659.1%

NBY Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.3%at low-45.5%+12.5%-27.6%at low
5 y5-year-16.3%+6.0%-45.5%+12.5%-46.4%at low
alltimeall time-42.6%+693.4%-61.2%+159.6%-9088.0%at low

NovaBay Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.65 M(+0.5%)
$13.40 M(+2.2%)
Jun 2024
-
$2.64 M(-21.2%)
$13.11 M(-1.0%)
Mar 2024
-
$3.35 M(-29.9%)
$13.24 M(+3.2%)
Dec 2023
$12.83 M(-16.1%)
$4.77 M(+102.5%)
$12.83 M(+3.2%)
Sep 2023
-
$2.36 M(-14.9%)
$12.44 M(-3.4%)
Jun 2023
-
$2.77 M(-5.7%)
$12.87 M(-8.4%)
Mar 2023
-
$2.94 M(-33.0%)
$14.05 M(-8.1%)
Dec 2022
$15.29 M(-0.3%)
$4.38 M(+56.9%)
$15.29 M(-3.1%)
Sep 2022
-
$2.79 M(-29.3%)
$15.77 M(-6.2%)
Jun 2022
-
$3.95 M(-5.2%)
$16.81 M(+3.7%)
Mar 2022
-
$4.17 M(-14.3%)
$16.22 M(+8.7%)
Dec 2021
$15.33 M(+26.7%)
$4.86 M(+26.9%)
$14.92 M(+16.1%)
Sep 2021
-
$3.83 M(+14.1%)
$12.85 M(+2.1%)
Jun 2021
-
$3.36 M(+17.1%)
$12.59 M(+3.8%)
Mar 2021
-
$2.87 M(+2.5%)
$12.13 M(+0.2%)
Dec 2020
$12.11 M(-14.0%)
$2.80 M(-21.7%)
$12.11 M(-4.2%)
Sep 2020
-
$3.57 M(+23.1%)
$12.64 M(+5.8%)
Jun 2020
-
$2.90 M(+2.2%)
$11.95 M(+1.4%)
Mar 2020
-
$2.84 M(-14.8%)
$11.78 M(-16.3%)
Dec 2019
$14.08 M(-24.4%)
$3.33 M(+15.8%)
$14.08 M(-8.8%)
Sep 2019
-
$2.88 M(+5.3%)
$15.43 M(-9.9%)
Jun 2019
-
$2.73 M(-46.8%)
$17.13 M(-8.6%)
Mar 2019
-
$5.14 M(+9.6%)
$18.73 M(+0.6%)
Dec 2018
$18.62 M(-16.7%)
$4.69 M(+2.5%)
$18.62 M(-0.6%)
Sep 2018
-
$4.57 M(+5.5%)
$18.73 M(-5.2%)
Jun 2018
-
$4.34 M(-13.6%)
$19.76 M(-3.8%)
Mar 2018
-
$5.02 M(+4.5%)
$20.54 M(-8.1%)
Dec 2017
$22.35 M(+17.3%)
$4.80 M(-14.4%)
$22.35 M(-1.5%)
Sep 2017
-
$5.61 M(+9.7%)
$22.69 M(+3.1%)
Jun 2017
-
$5.11 M(-25.1%)
$22.01 M(+4.6%)
Mar 2017
-
$6.83 M(+32.8%)
$21.05 M(+10.5%)
Dec 2016
$19.04 M(+2.8%)
$5.14 M(+4.3%)
$19.04 M(-4.7%)
Sep 2016
-
$4.93 M(+18.9%)
$19.99 M(+1.1%)
Jun 2016
-
$4.15 M(-14.1%)
$19.78 M(-0.6%)
Mar 2016
-
$4.83 M(-20.7%)
$19.89 M(+7.3%)
Dec 2015
$18.53 M
$6.09 M(+29.1%)
$18.53 M(+22.2%)
DateAnnualQuarterlyTTM
Sep 2015
-
$4.72 M(+10.8%)
$15.16 M(+22.7%)
Jun 2015
-
$4.26 M(+22.8%)
$12.35 M(+26.7%)
Mar 2015
-
$3.47 M(+27.7%)
$9.75 M(+22.0%)
Dec 2014
$7.99 M(+26.0%)
$2.72 M(+42.1%)
$7.99 M(+22.3%)
Sep 2014
-
$1.91 M(+15.6%)
$6.53 M(+6.3%)
Jun 2014
-
$1.65 M(-3.2%)
$6.14 M(-6.0%)
Mar 2014
-
$1.71 M(+35.7%)
$6.54 M(+2.3%)
Dec 2013
$6.34 M(+6.1%)
$1.26 M(-17.4%)
$6.39 M(-8.2%)
Sep 2013
-
$1.52 M(-25.4%)
$6.96 M(+4.4%)
Jun 2013
-
$2.04 M(+31.1%)
$6.67 M(+11.3%)
Mar 2013
-
$1.56 M(-14.7%)
$5.99 M(+0.3%)
Dec 2012
$5.97 M(+10.0%)
$1.83 M(+48.1%)
$5.97 M(+5.8%)
Sep 2012
-
$1.23 M(-9.8%)
$5.64 M(+2.5%)
Jun 2012
-
$1.37 M(-11.2%)
$5.50 M(+0.9%)
Mar 2012
-
$1.54 M(+2.8%)
$5.46 M(+0.5%)
Dec 2011
$5.43 M(-4.0%)
$1.50 M(+36.6%)
$5.43 M(+8.2%)
Sep 2011
-
$1.10 M(-16.8%)
$5.02 M(-7.2%)
Jun 2011
-
$1.32 M(-13.0%)
$5.41 M(-5.1%)
Mar 2011
-
$1.51 M(+39.4%)
$5.70 M(+0.8%)
Dec 2010
$5.65 M(+0.8%)
$1.09 M(-26.9%)
$5.65 M(-7.3%)
Sep 2010
-
$1.49 M(-7.7%)
$6.10 M(+3.0%)
Jun 2010
-
$1.61 M(+9.7%)
$5.92 M(+7.6%)
Mar 2010
-
$1.47 M(-3.9%)
$5.50 M(-2.0%)
Dec 2009
$5.61 M(-0.5%)
$1.53 M(+16.8%)
$5.61 M(+9.1%)
Sep 2009
-
$1.31 M(+9.9%)
$5.14 M(-4.4%)
Jun 2009
-
$1.19 M(-24.6%)
$5.38 M(-6.7%)
Mar 2009
-
$1.58 M(+48.8%)
$5.76 M(-1.8%)
Dec 2008
$5.64 M(+29.0%)
$1.06 M(-31.3%)
$5.86 M(-3.0%)
Sep 2008
-
$1.54 M(-2.0%)
$6.05 M(+9.5%)
Jun 2008
-
$1.57 M(-6.5%)
$5.52 M(+10.1%)
Mar 2008
-
$1.68 M(+35.5%)
$5.02 M(+14.9%)
Dec 2007
$4.37 M(+47.0%)
$1.24 M(+21.7%)
$4.37 M(+39.8%)
Sep 2007
-
$1.02 M(-4.5%)
$3.13 M(+48.5%)
Jun 2007
-
$1.07 M(+3.3%)
$2.10 M(+103.3%)
Mar 2007
-
$1.03 M
$1.03 M
Dec 2006
$2.97 M(+83.8%)
-
-
Dec 2005
$1.62 M
-
-

FAQ

  • What is NovaBay Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual SGA year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly SGA year-on-year change?
  • What is NovaBay Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals TTM SGA year-on-year change?

What is NovaBay Pharmaceuticals annual SGA?

The current annual SGA of NBY is $12.83 M

What is the all time high annual SGA for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual SGA is $22.35 M

What is NovaBay Pharmaceuticals annual SGA year-on-year change?

Over the past year, NBY annual SGA has changed by -$2.46 M (-16.07%)

What is NovaBay Pharmaceuticals quarterly SGA?

The current quarterly SGA of NBY is $2.65 M

What is the all time high quarterly SGA for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly SGA is $6.83 M

What is NovaBay Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, NBY quarterly SGA has changed by +$294.00 K (+12.48%)

What is NovaBay Pharmaceuticals TTM SGA?

The current TTM SGA of NBY is -$715.57 M

What is the all time high TTM SGA for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high TTM SGA is -$7.79 M

What is NovaBay Pharmaceuticals TTM SGA year-on-year change?

Over the past year, NBY TTM SGA has changed by -$728.00 M (-5853.52%)